Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Accumulated Depreciation & Amortization (2020 - 2022)

Historic Accumulated Depreciation & Amortization for Cullinan Therapeutics (CGEM) over the last 3 years, with Q4 2022 value amounting to $100000.0.

  • Cullinan Therapeutics' Accumulated Depreciation & Amortization changed 0.0% to $100000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $100000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $100000.0 for FY2022, which is 0.0% changed from last year.
  • Per Cullinan Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $100000.0 for Q4 2022, which was down 0.0% from $100000.0 recorded in Q4 2021.
  • Cullinan Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $179000.0 during Q4 2020, with a 5-year trough of $100000.0 in Q4 2021.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $100000.0 (2021), whereas its average is $126333.3.
  • As far as peak fluctuations go, Cullinan Therapeutics' Accumulated Depreciation & Amortization tumbled by 4413.41% in 2021, and later changed by 0.0% in 2022.
  • Over the past 3 years, Cullinan Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $179000.0 in 2020, then tumbled by 44.13% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022.
  • Its last three reported values are $100000.0 in Q4 2022, $100000.0 for Q4 2021, and $179000.0 during Q4 2020.